[Form 4] Esquire Financial Holdings, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Esquire Financial Holdings, Inc. reported that one of its directors received a grant of 753 shares of restricted common stock on December 10, 2025, at a stated price of $0 per share. These restricted shares are scheduled to vest 100% on December 10, 2026.
After this grant, the reporting person beneficially owns 59,400 shares of common stock, including multiple prior restricted stock awards that vest in annual installments from December 19, 2023 through December 15, 2027. The director also holds 1,500 fully vested stock options with an exercise price of $24.9 per share, expiring on December 10, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Powers Richard T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 753 | $0.00 | -- |
| holding | Stock Options | -- | -- | -- |
Holdings After Transaction:
Common Stock — 59,400 shares (Direct);
Stock Options — 1,500 shares (Direct)
Footnotes (1)
- Shares of restricted stock vest 100% on December 10, 2026. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027. Stock options are fully vested.